ClinicalTrials.gg
CompletedNCT01625117Updated Jun 26, 2013

Mental Health and Aggression in Congolese Ex-combatants

A Phase 2 interventional study of A variant of Narrative Exposure Therapy in Appetitive Aggression and Posttraumatic Stress Disorder, sponsored by University of Konstanz. Completed at 1 site in Congo. Open to male participants aged 16 Years to 35 Years. Per ClinicalTrials.gov, last updated 2013-06-26.

Sponsored by University of Konstanz · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
16 Years to 35 Years
Sex
Male
01

Study summary

The purpose of this study is examine, whether a treatment approach, which is specifically tailored for perpetrators who have participated in violence (a variant of Narrative Exposure Therapy) is effective in the reduction of instrumental aggression and symptoms of posttraumatic stress disorder.

Read the detailed description

The reintegration of former child soldiers and ex-combatants is a big challenge in war-torn countries. Former child soldiers and ex-combatants often suffer from mental health problems and show enhanced levels of aggression. The present study focuses on the reduction of appetitive aggression and the improvement of mental health in former child soldiers and ex-combatants in DR Congo.

02

Conditions studied

  • Appetitive Aggression
  • Posttraumatic Stress Disorder

Keywords

  • Treatment of ex-combatants
  • Narrative Exposure Therapy for ex-combatants
  • Appetitive Aggression
  • Posttraumatic Stress Disorder
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's enrollment of 38 is below the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

University of Konstanz is the lead sponsor of 51 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Ex-combatants in Congo who live in a re-integration camp
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • No intervention
    Control Group
  • Experimental
    A variant of Narrative exposure therapy

    Behavioral: A variant of Narrative Exposure Therapy

Interventions

  • BehavioralA variant of Narrative Exposure Therapy

    During the proposed therapy, the client constructs a chronological narrative of his or her whole life which includes all traumatic experiences and perpetrated violent acts. All emotions, cognitions, sensory information, and physiological reactions are activated and linked to the autobiographical context.In five sessions the therapist and the client try to go through all important traumatic experiences and perpetrated violent acts. The sixth session is a group session with four to five clients. The group session is oriented on Interpersonal Psychotherapy and focuses on the role change from soldier to civilian.

06

What researchers measure

Primary outcomes

  1. Appetitive aggression (Appetitive Aggression Scale)

    Time frame: 6 months

  2. Symptoms of posttraumatic stress disorder (Posttraumatic Diagnostic Scale, PDS)

    Time frame: 6 months

Secondary outcomes

  1. Symptoms of depression (Mini-International Neuropsychiatric Interview)

    Time frame: 6 months

  2. Functionality (Work and Social Adjustment Scale)

    Time frame: 6 months

07

Study locations

1 site
  • Reintegration camp for ex-combatants
    Goma, Congo
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01625117
Lead sponsor
University of Konstanz
Collaborators
German Research Foundation
Responsible party
Susanne Schaal (Susanne Schaal, University of Konstanz) — Principal investigator
First posted
Jun 21, 2012
Start date
May 2011
Primary completion
May 2012
Completion
Sep 2012
Last update
Jun 26, 2013

Study contacts

Thomas Elbert, Prof. Dr.
study director · University of Konstanz

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion